This federal contract award is for the delivery of the pharmaceutical product Ozempic (0.25-0.5 mg/dose, 3 mL pen) to the Defense Logistics Agency (DLA), a defense agency. The $25,376.35 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024 with a completion date of November 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Generated 2/25/25, 9:55 AM